Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

CDC42 Use in Viral Cell Entry Processes by RNA Viruses.

Swaine T, Dittmar MT.

Viruses. 2015 Dec 10;7(12):6526-36. doi: 10.3390/v7122955. Review.

2.

A whole genome screen for HIV restriction factors.

Liu L, Oliveira NM, Cheney KM, Pade C, Dreja H, Bergin AM, Borgdorff V, Beach DH, Bishop CL, Dittmar MT, McKnight A.

Retrovirology. 2011 Nov 14;8:94. doi: 10.1186/1742-4690-8-94.

3.

Fitness ranking of individual mutants drives patterns of epistatic interactions in HIV-1.

Martínez JP, Bocharov G, Ignatovich A, Reiter J, Dittmar MT, Wain-Hobson S, Meyerhans A.

PLoS One. 2011 Mar 31;6(3):e18375. doi: 10.1371/journal.pone.0018375.

4.

Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.

Sarfo FS, Bibby DF, Schwab U, Appiah LT, Clark DA, Collini P, Phillips R, Green I, Dittmar MT, Chadwick DR.

J Antimicrob Chemother. 2009 Sep;64(3):667-9. doi: 10.1093/jac/dkp216. Epub 2009 Jun 23. No abstract available.

PMID:
19549668
5.

Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.

Malinowsky K, Luksza J, Dittmar MT.

Virology. 2008 Jun 20;376(1):69-78. doi: 10.1016/j.virol.2008.02.034. Epub 2008 Apr 8.

6.

Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses.

Antoni S, Walz N, Landersz M, Humbert M, Seidl C, Dittmar MT, Dietrich U.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1377-86. doi: 10.1089/aid.2007.0113.

PMID:
18184081
7.

Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.

Humbert M, Antoni S, Brill B, Landersz M, Rodes B, Soriano V, Wintergerst U, Knechten H, Staszewski S, von Laer D, Dittmar MT, Dietrich U.

Eur J Immunol. 2007 Feb;37(2):501-15.

8.
9.

Inhibition of HIV-1 group M and O isolates by fusion inhibitors.

Chinnadurai R, Münch J, Dittmar MT, Kirchhoff F.

AIDS. 2005 Nov 4;19(16):1919-22.

PMID:
16227804
10.

Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides.

Lohrengel S, Hermann F, Hagmann I, Oberwinkler H, Scrivano L, Hoffmann C, von Laer D, Dittmar MT.

J Virol. 2005 Aug;79(16):10237-46.

11.

In vitro inhibition of R5 HIV-1 infectivity by X4 V3-derived synthetic peptides.

Baritaki S, Dittmar MT, Spandidos DA, Krambovitis E.

Int J Mol Med. 2005 Aug;16(2):333-6.

PMID:
16012771
12.

T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells.

Neumann T, Hagmann I, Lohrengel S, Heil ML, Derdeyn CA, Kräusslich HG, Dittmar MT.

Virology. 2005 Mar 15;333(2):251-62.

13.

Role of HIV-2 envelope in Lv2-mediated restriction.

Reuter S, Kaumanns P, Buschhorn SB, Dittmar MT.

Virology. 2005 Feb 5;332(1):347-58.

14.

Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry.

Daecke J, Fackler OT, Dittmar MT, Kräusslich HG.

J Virol. 2005 Feb;79(3):1581-94.

15.

Trimeric membrane-anchored gp41 inhibits HIV membrane fusion.

Lenz O, Dittmar MT, Wagner A, Ferko B, Vorauer-Uhl K, Stiegler G, Weissenhorn W.

J Biol Chem. 2005 Feb 11;280(6):4095-101. Epub 2004 Dec 1.

16.

Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.

Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG.

J Virol. 2004 Oct;78(19):10803-13.

18.

Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

Kirchhoff F, Schindler M, Bailer N, Renkema GH, Saksela K, Knoop V, Müller-Trutwin MC, Santiago ML, Bibollet-Ruche F, Dittmar MT, Heeney JL, Hahn BH, Münch J.

J Virol. 2004 Jul;78(13):6864-74.

19.

Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A.

J Virol. 2004 Feb;78(4):2006-16.

20.

HIV: epidemiology and strategies for therapy and vaccination.

Marcus U, Dittmar MT, Kräusslich HG.

Intervirology. 2002;45(4-6):260-6. Review.

PMID:
12566708
21.
22.

A recombinant virus assay using full-length envelope sequences to detect changes in HIV-1 co-receptor usage.

Dittmar MT, Eichler S, Reinberger S, Henning L, Kräusslich HG.

Virus Genes. 2001 Dec;23(3):281-90.

PMID:
11778696
23.

Membrane-anchored peptide inhibits human immunodeficiency virus entry.

Hildinger M, Dittmar MT, Schult-Dietrich P, Fehse B, Schnierle BS, Thaler S, Stiegler G, Welker R, von Laer D.

J Virol. 2001 Mar;75(6):3038-42.

24.

Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.

Polzer S, Dittmar MT, Schmitz H, Meyer B, Müller H, Kräusslich HG, Schreiber M.

Glycobiology. 2001 Jan;11(1):11-9.

PMID:
11181557
25.

Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon.

Dittmar MT, Zekeng L, Kaptue L, Eberle J, Kräusslich HG, Gürtler L.

AIDS Res Hum Retroviruses. 1999 May 20;15(8):707-12.

PMID:
10357466
26.

A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

McKnight A, Dittmar MT, Moniz-Periera J, Ariyoshi K, Reeves JD, Hibbitts S, Whitby D, Aarons E, Proudfoot AE, Whittle H, Clapham PR.

J Virol. 1998 May;72(5):4065-71.

27.

The U3 promoter and the nef gene of simian immunodeficiency virus (SIV) smmPBj1.9 do not confer acute pathogenicity upon SIVagm.

Wagener S, Dittmar MT, Beer B, König R, Plesker R, Norley S, Kurth R, Cichutek K.

J Virol. 1998 Apr;72(4):3446-50.

28.

Different subtypes of HIV-1 and cutaneous dendritic cells.

Pope M, Ho DD, Moore JP, Weber J, Dittmar MT, Weiss RA.

Science. 1997 Oct 31;278(5339):786-8. No abstract available.

PMID:
9381184
29.

Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Dittmar MT, Simmons G, Hibbitts S, O'Hare M, Louisirirotchanakul S, Beddows S, Weber J, Clapham PR, Weiss RA.

J Virol. 1997 Oct;71(10):8008-13.

30.

Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Dittmar MT, Simmons G, Donaldson Y, Simmonds P, Clapham PR, Schulz TF, Weiss RA.

J Virol. 1997 Jul;71(7):5140-7.

31.

HIV-1 tropism and co-receptor use.

Dittmar MT, McKnight A, Simmons G, Clapham PR, Weiss RA, Simmonds P.

Nature. 1997 Feb 6;385(6616):495-6. No abstract available.

PMID:
9020356
32.

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR.

J Virol. 1996 Dec;70(12):8355-60.

33.

An in vitro assay for acute pathogenicity of immunodeficiency viruses.

Dittmar MT, Wagener S, Fultz P, Kurth R, Cichutek K.

Dev Biol Stand. 1996;86:167-73.

PMID:
8785946
34.
35.

CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.

Ennen J, Findeklee H, Dittmar MT, Norley S, Ernst M, Kurth R.

Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7207-11.

36.

Development of vivo of genetic variability of simian immunodeficiency virus.

Baier M, Dittmar MT, Cichutek K, Kurth R.

Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8126-30.

Supplemental Content

Loading ...
Support Center